Clinical Trial Update: Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).

View source ↗

Summary

A clinical trial investigating the impact of the omega-6 to omega-3 fatty acid ratio on the progression of age-related macular degeneration has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: Yves Sauve | Conditions: Age-related Macular Degeneration | Status: TERMINATED